Introduction {#sec1}
============

As poly cyclic nitrogen-containing heterocycles, 8*H*-isoquinolino\[1,2-*b*\]quinazolin-8-ones and phthalazino\[2,3-*a*\]cinnoline-8,13-diones are ubiquitous in many bioactive synthetic compounds as well as natural products ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). For example, compounds **A** and **B** as shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} were proved to have efficient antitumor activities.^[@ref1],[@ref2]^ Poly cyclic nitrogen-containing heterocycles were also commonly applied in anticonvulsant,^[@ref3]−[@ref5]^ anti-inflammatory,^[@ref6]^ antiallergy,^[@ref7],[@ref8]^ antimicrobial,^[@ref9]^ cardiotonic,^[@ref10]^ and cell imaging^[@ref11],[@ref12]^ research. Scaffold of 11*H*-pyrido\[2,1-*b*\]quinazolin-11-one **H** was found in many natural products^[@ref13]^ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Traditional synthesis of such polycyclic compounds suffered from multiple steps and harsh reaction conditions. Thus, developing general and efficient approaches for the construction of 8*H*-isoquinolino\[1,2-*b*\]quinazolin-8-one and phthalazino\[2,3-*a*\]cinnoline-8,13-dione derivatives attracted a lot of efforts. For example, Peng and Cui developed ruthenium and palladium catalyzed directed C--H bond activation of 2-phenylquinazolin-4(3*H*)-ones and alkyne insertion annulations for the synthesis of 8*H*-isoquinolino\[1,2-*b*\]quinazolin-8-ones, respectively ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref14],[@ref15]^ Synthesis of phthalazino\[2,3-*a*\]cinnoline-8,13-diones was independently reported by Gandhi and Perumal via ruthenium and rhodium catalyzed alkyne insertion reactions with 2-phenyl-2,3-dihydrophthalazine-1,4-diones.^[@ref16],[@ref17]^

![Representative Bioactive Molecules](ao-2018-01930a_0001){#sch1}

![Transition-Metal Catalyzed C--H Activation Reactions of 2-Phenylquinazolin-4(3*H*)-ones and 2-Phenyl-2,3-dihydrophthalazine-1,4-diones](ao-2018-01930a_0002){#sch2}

Transition-metal catalyzed C--H bond activation reactions have been a long-term research interest of organic chemists for the construction of new C--C and C--X (X = N, O, S et al.) bonds because of the environmental benignity and simple operation. As a C1 building block, carbene has attracted much attention based on its high and diverse reaction reactivities.^[@ref18]−[@ref21]^ 1,3-Diketone-2-diazo compounds can not only react as a C1 synthon but also be used as an equivalent of alkynes, undergoing formal C2 insertion reaction with cyclic compounds being constructed.^[@ref22]^ However, compared with alkynes, 1,3-diketone-2-diazo compounds have their unique characteristics. For instance, no additional oxidants, to which lots of substrates cannot tolerate, were needed. Additionally, cyclic 1,3-diketone-2-diazo compounds have their priorities because of the instability of cyclic alkynes.^[@ref23]^ Herein, we report facile access to 8*H*-isoquinolino\[1,2-*b*\]quinazolin-8-ones and phthalazino\[2,3-*a*\]cinnoline-8,13-diones via ruthenium and iridium catalyzed C--H bond activation/annulation reaction of cyclic amide derivatives. In these reactions, both cyclic and acyclic 1,3-diketone-2-diazo compounds could be transformed to corresponding products smoothly in good to excellent yields with H~2~O and N~2~ as the only byproducts.

Results and Discussion {#sec2}
======================

The reaction was initiated with 2-(*p*-tolyl)quinazolin-4(3*H*)-one (**1a**) and 2-diazo-5-methylcyclohexane-1,3-dione (**2a**) as model substrates with the catalysis of (RhCp\*Cl~2~)~2~/AgNTf~2~ at 90 °C ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). To our delight, the desired product 2,6-dimethyl-2,3-dihydro-4*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14(1*H*)-dione (**3a**) was obtained in 58% yield. Screening of catalysts revealed that 3 mol % of \[(*p*-cymene)RuCl~2~\]~2~ gave the best result (entries 2--5). Further investigation of additives and solvents showed lower efficacy (entries 6--11). In addition, no better results were found at lower or higher reaction temperatures (80 and 100 °C).

###### Optimization of Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-01930a_0006){#GRAPHIC-d7e427-autogenerated}

  entry   catalyst (mol %)                 additive (30 mol %)   solvent    temp. (°C)   time (min)   yield (%)[b](#t1fn2){ref-type="table-fn"}
  ------- -------------------------------- --------------------- ---------- ------------ ------------ -------------------------------------------
  1       (RhCp\*Cl~2~)~2~ (3)             AgNTf~2~              *t*-BuOH   90           40           58
  2       (IrCp\*Cl~2~)~2~ (3)             AgNTf~2~              *t*-BuOH   90           40           47
  3       \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              *t*-BuOH   90           40           73
  4       \[(*p*-cymene)RuCl~2~\]~2~ (1)   AgNTf~2~              *t*-BuOH   90           40           49
  5       \[(*p*-cymene)RuCl~2~\]~2~ (5)   AgNTf~2~              *t*-BuOH   90           40           66
  6       \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgSbF~6~              *t*-BuOH   90           40           51
  7       \[(*p*-cymene)RuCl~2~\]~2~ (3)   CsOAc                 *t*-BuOH   90           40           40
  8       \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              DMF        90           40           58
  9       \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              DCE        90           40           40
  10      \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              toluene    90           40           31
  11      \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              *t*-AmOH   90           40           66
  12      \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              *t*-BuOH   80           40           41
  13      \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~              *t*-BuOH   100          40           29

Reaction conditions: **1a** (0.50 mmol), **2a** (0.5 mmol) in the presence of catalyst/additive in 5 mL of solvent under air.

Isolated yields.

With the optimized conditions in hand, the substrate scope of 2-phenylquinazolin-4(3*H*)-one derivatives were investigated first ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Substituents such as OMe, OBn, Br, ^*t*^Bu, Cl, and OH on the aromatic rings were well tolerated under the optimal conditions, generating the corresponding products in moderate-to-good yields (**3a**--**3i**). It is worthy to note that the substrate with the hydroxyl group which is intolerable under many reaction conditions could be transformed to product **3i** in an acceptable 50% yield. When phenyl, dimethyl, or nonsubstituted cyclic diazo compounds worked as the reactants, products **3j**--**3l** were obtained in moderate yields. Meanwhile, heterocyclic C--H bond activation was realized to generate **3m** in 68% yield. However, acyclic 1,3-diketone-2-diazo compounds failed to suffer the reaction conditions.

![Scope of the Reaction with 2-Phenylquinazolin-4(3*H*)-ones\
Reaction conditions: **1** (0.50 mmol), **2** (0.5 mmol), \[(*p*-cymene)RuCl~2~\]~2~ (3 mol %), AgNTf~2~ (30 mol %), 5 mL of ^*t*^BuOH, 90 °C. Isolated yields.](ao-2018-01930a_0003){#sch3}

Other types of cyclic amide-directed C--H bond activations were further investigated with easily accessible 2-phenyl-2,3-dihydrophthalazine-1,4-dione (**4a**) and 2-diazo-5,5-dimethylcyclohexane-1,3-dione (**2b**) as model substrates. With the above optimized catalytic system at a higher temperature of 100 °C, 2,2-dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5a**) was generated in 60% yield ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 1). After optimization of the reaction conditions, the yield of **5a** was increased to 93% under the condition of (IrCp\*Cl~2~)~2~/AgSbF~6~ as catalyst in DCE at 100 °C (entry 3).

###### Optimization of Reaction Conditions for Synthesis of **5a**[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-01930a_0007){#GRAPHIC-d7e1066-autogenerated}

  entry   catalyst (mol %)                 additive (mol %)   solvent    temp. (°C)   time (h)   yield (%)[b](#t2fn2){ref-type="table-fn"}
  ------- -------------------------------- ------------------ ---------- ------------ ---------- -------------------------------------------
  1       \[(*p*-cymene)RuCl~2~\]~2~ (3)   AgNTf~2~ (30)      *t*-BuOH   100          14         60
  2       (IrCp\*Cl~2~)~2~ (1.5)           AgSbF~6~ (20)      DCE        100          14         67
  3       (IrCp\*Cl~2~)~2~ (2)             AgSbF~6~ (20)      DCE        100          14         93
  4       (IrCp\*Cl~2~)~2~ (2.5)           AgSbF~6~ (20)      DCE        100          14         70
  5       (IrCp\*Cl~2~)~2~ (2)             AgSbF~6~ (10)      DCE        100          14         68
  6       (IrCp\*Cl~2~)~2~ (2)             AgSbF~6~ (30)      DCE        100          14         56
  7       (IrCp\*Cl~2~)~2~ (2.5)           AgSbF~6~ (20)      acetone    100          14         32
  8       (RhCp\*Cl~2~)~2~ (2)             AgSbF~6~ (30)      THF        100          14         10

Reaction conditions: **1a** (0.50 mmol), **4a** (0.5 mmol), catalyst/additive (as indicated in the table), 5 mL solvent, 14 h, nitrogen atmosphere.

Isolated yields.

Next, the scope of the reaction was investigated under the optimized conditions ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Substrates with Me, ^*t*^Bu, F, Cl, and Br underwent the reaction efficiently with 2-diazo-5,5-dimethylcyclohexane-1,3-dione (**2b**), generating the corresponding products in good to excellent yields (**5a**--**5i**). Steric hindered ortho-substituted substrates could tolerate the reaction conditions, generating **5g** and **5h** in 81 and 82% yields, respectively. Diverse poly cyclic heterocycles were obtained in good yields when using monomethyl, phenyl, and nonsubstituted cyclic diazo compounds as the reaction partners (**5j**--**5r**). It is worthy to note that five-membered-cyclic and acyclic 1,3-carbonyl-2-diazo compounds tolerated the reaction conditions, generating the corresponding products **5s**--**5x** in excellent yields.

![Scope of the Reaction with 2-Phenyl-2,3-dihydrophthalazine-1,4-diones\
Reaction conditions: **4** (0.5 mmol), **2** (0.5 mmol), (IrCp\*Cl~2~)~2~ (2 mol %), AgSbF~6~ (20 mol %), 5 mL of DCE, 100 °C. Isolated yields.](ao-2018-01930a_0004){#sch4}

On the basis of the reported transition-metal-catalyzed C--H bond activation/carbene insertion reactions^[@ref22],[@ref23],[@ref24]^ and the experiment results, a possible mechanism was proposed in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}. An active catalytic species **I** was generated by ligand exchange, which catalyzed C--H bond activation to form intermediate **II**. Carbene coordination and migratory insertion to intermediate **II** generated alkyl-ruthenium intermediate **IV**, which was then protonated to intermediate **V**. The catalyst **I** was released to complete the catalytic cycle. An isomerization/intramolecular condensation process of **V** took place spontaneously, affording the compound **3**.

![Proposed Reaction Mechanism](ao-2018-01930a_0005){#sch5}

Conclusion {#sec3}
==========

In conclusion, we have developed an efficient and practical method for the synthesis of 8*H*-isoquinolino\[1,2-*b*\]quinazolin-8-one and phthalazino\[2,3-*a*\]cinnoline-8,13-dione derivatives via ruthenium and iridium catalyzed C--H bond activation reactions. Diverse nitrogen-containing poly cyclic compounds were synthesized effectively under mild conditions. The reaction proceeds through consecutive C--H bond activation, carbene insertion, and annulation reaction with water and N~2~ as the only byproducts, revealing the environmental benignity of this reaction.

Experimental Section {#sec4}
====================

General Comments {#sec4.1}
----------------

Unless otherwise specified, all reagents and starting materials were purchased from commercial sources and used as received and the solvents were purified and dried using standard procedures. The chromatography solvents were of technical grade and distilled prior to use. Flash chromatography was performed using 200--300 mesh silica gel with the indicated solvent system according to standard techniques. The ^1^H and ^13^C NMR data were recorded on 300/500 and 75/125 MHz NMR spectrometers, unless otherwise specified. Chemical shifts (δ) in parts per million are reported relative to the residual signals of chloroform (7.26 ppm for ^1^H and 77.16 ppm for ^13^C), and all ^13^C NMR were recorded with proton broadband decoupling and indicated as ^13^C{^1^H} NMR. Multiplicities are described as s (singlet), d (doublet), t (triplet), q (quartet), or m (multiplet), and the coupling constants (*J*) are reported in hertz. HRMS analysis with a quadrupole time-of-flight mass spectrometer yielded ion mass/charge (*m*/*z*) ratios in atomic mass units. IR spectra were measured as dry films (KBr), and the peaks are reported in terms of wave number (cm^--1^).

Procedure A: The Synthesis of 8*H*-Isoquinolino\[1,2-*b*\]quinazolin-8-one Derivatives **3** {#sec4.2}
--------------------------------------------------------------------------------------------

To a solution of 2-(*p*-tolyl)quinazolin-4(3*H*)-one (0.5 mmol) and \[(*p*-cymene)RuCl~2~\]~2~ (3 mol %)/AgNTf~2~ (30 mol %) in *t*-BuOH (2 mL) at 90 °C was added portion wise a solution of 2-diazo-5-methylcyclohexane-1,3-dione (0.5 mmol). After being stirred for another 40 min, the mixture was cooled to room temperature. The reaction was quenched with water, and the mixture was extracted with DCM three times. The combined organic layers were dried over anhydrous Na~2~SO~4~, filtered and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel to afford 2,6-dimethyl-2,3-dihydro-4*H*-quinazolino\[3,2-*f*\] phenanthridine-4,14(1*H*)-dione **3**.

Procedure B: The Synthesis of Phthalazino\[2,3-*a*\]cinnoline-8,13-dione Derivatives **5** {#sec4.3}
------------------------------------------------------------------------------------------

A mixture of cyclic 2-diazo-1,3-diketones **2** (0.5 mmol), 2-phenyl-2,3-dihydrophthalazine-1,4-dione **4** (0.5 mmol), \[Cp\*IrCl~2~\]~2~ (2 mol %), and AgSbF~6~ (20 mol %) in DCE (2 mL) was heated in an oil bath at 100 °C for 14 h. Upon completion of the reaction, the mixture was cooled to room temperature. The residue was purified by flash column chromatography on silica gel (200--300 mesh) with ethyl acetate and petroleum ether (1:6--1:8, v/v) as the elution solvent to give the desired products **5**.

### 2-Methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3a**) {#sec4.3.1}

Yellow solid. 124 mg, 73% yield; mp: 221--223 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.88 (s, 1H), 8.85--8.76 (m, 1H), 8.27 (d, *J* = 8.0 Hz, 1H), 7.86--7.77 (m, 2H), 7.47 (m, 1H), 7.40 (d, *J* = 8.0 Hz, 1H), 3.48 (dd, *J* = 18.5, 11.0 Hz, 1H), 3.37--3.18 (m, 1H), 2.80--2.77 (m, 1H), 2.53 (s, 3H), 2.49 (dd, *J* = 17.0, 13.0 Hz, 1H), 2.26--2.12 (br s, 1H), 1.16 (d, *J* = 6.5 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 198.3, 161.6, 149.3, 147.2, 146.1, 143.9, 135.3, 129.9, 129.7, 127.2, 27.1, 126.5, 126.4, 126.2, 119.8, 118.5, 105.0, 47.1, 39.1, 30.2, 22.5, 20. 6; IR(KBr) ν: 2912, 1693, 1664, 1595, 1546, 1323, 761 cm^--1^; HRMS (ESI) calcd for C~22~H~18~N~2~O~2~ \[M + H\]^+^, 343.1441; found, 343.1448.

### 2-Methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3b**) {#sec4.3.2}

Yellow solid. 100 mg, 61% yield; mp: 218--220 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.08 (d, *J* = 8.1 Hz, 1H), 8.97 (d, *J* = 7.8 Hz, 1H), 8.28 (d, *J* = 7.8 Hz, 1H), 7.86 (br s, 2H), 7.72 (t, *J* = 7.2 Hz, 1H), 7.60 (t, *J* = 7.2 Hz, 1H), 7.50 (dd, *J* = 9.6, 4.1 Hz, 1H), 3.50 (dd, *J* = 18.3, 10.8 Hz, 1H), 3.26 (d, *J* = 18.3 Hz, 1H), 2.79 (d, *J* = 16.8 Hz, 1H), 2.50 (dd, *J* = 16.5, 12.9 Hz, 1H), 2.22 (s, 1H), 1.17 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 198.1, 162.2, 149.8, 146.8, 146.5, 135.3, 132.6, 129.6, 128.4, 127.0, 127.0, 126.820, 126.4, 126.3, 120.1, 118.3, 47.4, 39.2, 30.0, 21.0; IR(KBr) ν: 2933, 1693, 1664, 1595, 1562, 1458, 1325, 1195, 765, 698 cm^--1^; HRMS (ESI) calcd for C~21~H~16~N~2~O~2~ \[M + H\]^+^, 329.1285; found, 329.1282.

### 6-Methoxy-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3c**) {#sec4.3.3}

Yellow solid. 94 mg, 53% yield; mp: 207--209 °C; ^1^H NMR (300 MHz, C~6~D~6~): δ 9.03 (d, *J* = 8.7 Hz, 1H), 8.72 (s, 1H), 8.26 (d, *J* = 7.8 Hz, 1H), 7.95 (d, *J* = 7.5 Hz, 1H), 7.83 (t, *J* = 7.2 Hz, 1H), 7.47 (t, *J* = 7.5 Hz, 1H), 7.20 (d, *J* = 9.0 Hz, 1H), 3.98 (s, 3H), 3.51 (dd, *J* = 18.3, 10.8 Hz, 1H), 3.26 (d, *J* = 17.7 Hz, 1H), 2.79 (d, *J* = 16.8 Hz, 1H), 2.64--2.39 (m, 1H), 2.22 (s, 1H), 1.18 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 198.2, 163.7, 162.0, 150.6, 147.1, 135.5, 131.9, 129.3, 127.1, 126.1, 126.0, 119.4, 118.1, 117.7, 108.4, 55.7, 47.4, 39.4, 30.0, 21.0; IR (KBr) ν: 2964, 1691, 1666, 1595, 1544, 1363, 1379, 1319, 1026, 771 cm^--1^; HRMS (ESI) calcd for C~22~H~18~N~2~O~3~ \[M + H\]^+^, 359.1390; found, 359.1394.

### 6-Bromo-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3d**) {#sec4.3.4}

Yellow solid. 70 mg, 35% yield; mp: 215--217 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.30 (d, *J* = 1.5 Hz, 1H), 8.76 (d, *J* = 8.7 Hz, 1H), 8.26 (d, *J* = 7.8 Hz, 1H), 7.82 (q, *J* = 8.1 Hz, 2H), 7.66 (d, *J* = 8.7 Hz, 1H), 7.50 (t, *J* = 6.6 Hz, 1H), 3.48 (dd, *J* = 18.6, 10.8 Hz, 1H), 3.25 (d, *J* = 17.1 Hz, 1H), 2.77 (d, *J* = 16.5 Hz, 1H), 2.47 (dd, *J* = 16.8, 12.8 Hz, 1H), 2.20 (s, 1H), 1.17 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 197.6, 162.0, 151.2, 146.3, 146.3, 135.4, 131.7, 130.9, 129.2, 128.6, 128.1, 127.1, 127.0, 126.6, 125.6, 120.2, 117.1, 47.2, 39.3, 29.9, 21.0; IR (KBr) ν: 2953, 1703, 1666, 1585, 1546, 1394, 1319, 912, 831, 771, 698 cm^--1^; HRMS (ESI) calcd for C~21~H~15~BrN~2~O~2~ \[M + H\]^+^, 345.1234; found, 345.1239.

### 6-(Benzyloxy)-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3e**) {#sec4.3.5}

Yellow solid. 98 mg, 46% yield; mp: 208--210 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 8.90 (d, *J* = 8.7 Hz, 1H), 8.82 (d, *J* = 1.8 Hz, 1H), 8.26 (d, *J* = 7.8 Hz, 1H), 7.81 (d, *J* = 3.6 Hz, 2H), 7.65--7.08 (m, 7H), 5.24 (s, 2H), 3.50 (dd, *J* = 18.3, 10.7 Hz, 1H), 3.27 (d, *J* = 17.7 Hz, 1H), 2.79 (d, *J* = 15.9 Hz, 1H), 2.64--2.35 (m, 1H), 2.21 (s, 1H), 1.17 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 198.3, 178.3, 162.3, 150.8, 150.1, 148.1, 146.9, 136.3, 135.2, 131.5, 129.9, 129.0, 128.6, 128.2, 127.8, 127.0, 126.7, 125.7, 119.7, 117.0, 118.86, 109.3, 103.1, 70.2, 47.4, 39.4, 29.9, 20.9; IR (KBr) ν: 2922, 1693, 1674, 1600, 1541, 1498, 1379, 1325, 1242, 1014, 886, 771, 692 cm^--1^; HRMS (ESI) calcd for C~28~H~22~N~2~O~3~ \[M + H\]^+^, 435.1703; found, 435.1696.

### 6-(*tert*-Butyl)-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3f**) {#sec4.3.6}

Yellow solid. 85 mg, 45% yield; mp: 173--175 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.19 (d, *J* = 8.4 Hz, 1H), 8.88 (d, *J* = 8.7 Hz, 1H), 8.28 (d, *J* = 7.8 Hz, 1H), 7.82 (d, *J* = 13.5 Hz, 2H), 7.66 (d, *J* = 8.5 Hz, 1H), 7.49 (d, *J* = 7.8 Hz, 1H), 3.50 (dd, *J* = 18.3, 10.6 Hz, 1H), 3.26 (d, *J* = 18.0 Hz, 1H), 2.79 (d, *J* = 14.7 Hz, 1H), 2.66--2.36 (m, 1H), 2.22 (s, 1H), 1.45 (d, *J* = 9.9 Hz, 9H), 1.17 (d, *J* = 6.4 Hz, 3); ^13^C NMR (75 MHz, CDCl~3~): δ 198.3, 162.2, 156.4, 149.7, 146.9, 146.6, 135.2, 129.5, 127.0, 126.8, 126.2, 126.0, 124.3,122.9, 120, 118.6, 47.5, 39.2, 35.6, 31.2, 30.0, 20.9; IR (KBr) ν: 2958, 1703, 1670, 1593, 1546, 1465, 1373, 1259, 777, 729 cm^--1^; HRMS (ESI) calcd for C~25~H~24~rN~2~O~2~ \[M + H\]^+^, 385.1911; found, 385.1912.

### 12-Chloro-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3g**) {#sec4.3.7}

Yellow solid. 112 mg, 63% yield; mp: 213--215 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.07 (d, *J* = 8.1 Hz, 1H), 8.89 (d, *J* = 7.8 Hz, 1H), 8.23 (s, 1H), 7.89--7.64 (m, 3H), 7.58 (t, *J* = 7.5 Hz, 1H), 3.47 (dd, *J* = 18.3, 10.8 Hz, 1H), 3.22 (d, *J* = 17.1 Hz, 1H), 2.78 (d, *J* = 16.5 Hz, 1H), 2.49 (dd, *J* = 16.5, 12.9 Hz, 1H), 2.21 (s, 1H), 1.17 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 198.0, 161.2, 149.5, 145.1, 135.6, 132.7, 131.8, 129.5, 128.7, 128.4, 126.9, 126.7, 126.4, 126.2, 121.0, 118.5, 47.3, 39.1, 29.9, 20.9; IR (KBr) ν: 2958, 1697, 1670, 1595, 1562, 1544, 1463, 1322, 1296, 1064, 837, 771, 690 cm^--1^; HRMS (ESI) calcd for C~21~H~15~Cl N~2~O~2~ \[M + H\]^+^, 363.0895; found, 363.0895.

### 7-Chloro-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3h**) {#sec4.3.8}

Yellow solid. 81 mg, 46% yield; mp: 220--222 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.09--8.74 (m, 2H), 8.27 (d, *J* = 7.8 Hz, 1H), 7.83 (d, *J* = 6.3 Hz, 2H), 7.49 (t, *J* = 6.3 Hz, 1H), 7.37--7.11 (m, 1H), 3.50 (dd, *J* = 18.3, 10.8 Hz, 1H), 3.26 (d, *J* = 18.3 Hz, 1H), 2.78 (d, *J* = 16.8 Hz, 1H), 2.60--2.35 (m, 1H), 2.21 (s, 1H), 1.17 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 197.7, 162.1, 152.5, 151.3, 146.3, 135.3, 129.8, 129.7, 127.1, 126.8, 126.3, 119.9, 116.7, 116.4, 112.8, 112.5, 47.2, 39.2, 29.9, 20.9; IR (KBr) ν: 2964, 1693, 1664, 1598, 1550, 1490, 1323, 771 cm^--1^; HRMS (ESI) calcd for C~21~H~15~Cl N~2~O~2~ \[M + H\]^+^, 363.0895; found, 363.0900.

### 8-Hydroxy-2-methyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3i**) {#sec4.3.9}

Yellow solid. 85 mg, 50% yield; mp: 197--199 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 15.01 (s, 1H), 8.51 (d, *J* = 8.1 Hz, 1H), 8.28 (d, *J* = 7.8 Hz, 1H), 7.84 (t, *J* = 7.5 Hz, 1H), 7.70 (d, *J* = 8.1 Hz, 1H), 7.62 (t, *J* = 8.1 Hz, 1H), 7.51 (t, *J* = 7.5 Hz, 1H), 7.11 (d, *J* = 8.1 Hz, 1H), 3.44 (dd, *J* = 18.3, 10.8 Hz, 1H), 3.18 (d, *J* = 17.1 Hz, 1H), 2.78 (d, *J* = 16.8 Hz, 1H), 2.48 (dd, *J* = 16.8, 12.6 Hz, 1H), 2.20 (s, 1H), 1.17 (d, *J* = 6.6 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 197.5, 161.1, 152.5, 150.0, 148.6, 143.8, 135.6, 134.9, 130.2, 127.3, 126.6, 125.0, 119.8, 119.4, 116.9, 116.5, 47.4, 39.0, 29.8, 20.9; IR (KBr) ν: 3419, 2958, 1708, 1664, 1598, 1544, 14 958, 1334, 1269, 810, 758, 696 cm^--1^; HRMS (ESI) calcd for C~21~H~16~N~2~O~3~ \[M + H\]^+^, 345.1234; found, 345.1233.

### 6-(Benzyloxy)-2-phenyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3j**) {#sec4.3.10}

Yellow solid. 111 mg, 45% yield; mp: 217--219 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.19 (d, *J* = 8.4 Hz, 1H), 8.90 (s, 1H), 8.21 (d, *J* = 7.5 Hz, 1H), 8.08 (d, *J* = 7.5 Hz, 1H), 7.90--7.73 (m, 1H), 7.64--7.17 (m, 10H), 5.28 (s, 2H), 4.02 (dd, *J* = 18.0, 11.5 Hz, 2H), 3.70--3.22 (m, 2H), 3.22--2.83 (m, 2H); ^13^C NMR (125 MHz, CDCl~3~): δ 197.3 163.2 161.6, 149.9, 146.9, 141.9, 136.1, 135.7, 132.0, 129.7, 129.0, 128.7, 128.3, 127.8, 127.5, 127.2, 126.9, 126.2, 125.8, 119.1, 118.6, 109.5, 77.3, 77.0, 76.8, 70.4, 46.1, 40.5, 39.1; IR (KBr) ν: 2922, 1697, 1664, 1593, 1562, 1541, 1492, 1361, 1238, 1014, 771, 696 cm^--1^; HRMS (ESI) calcd for C~33~H~24~N~2~O~3~ \[M + H\]^+^, 497.1860; found, 497.1861.

### 6-(Benzyloxy)-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3k**) {#sec4.3.11}

Yellow solid. 96 mg, 46% yield; mp: 169--171 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 9.06 (d, *J* = 8.7 Hz, 1H), 8.82 (d, *J* = 2.1 Hz, 1H), 8.26 (d, *J* = 7.8 Hz, 1H), 7.96 (d, *J* = 8.1 Hz, 1H), 7.83 (t, *J* = 7.5 Hz, 1H), 7.44 (m, 5H), 7.27 (d, *J* = 7.5 Hz, 2H), 5.25 (s, 2H), 3.52 (t, *J* = 5.7 Hz, 2H), 2.90--2.69 (m, 2H), 2.15--1.97 (m, 2H); ^13^C NMR (125 MHz, CDCl~3~): δ 198.0, 162.7, 162.0, 151.3, 146.9, 136.2, 135.5, 129.4, 128.7, 128.3, 127.8, 127.1, 126.0, 118.2, 109.4, 105.0, 70.3, 39.5, 31.5, 22.5; IR (KBr) ν: 2933, 1693, 1660, 1550, 1367, 1301, 1236, 1010, 767, 692 cm^--1^; HRMS (ESI) calcd for C~27~H~20~N~2~O~3~ \[M + H\]^+^, 421.1547; found, 421.1541.

### 6-(Benzyloxy)-2,2-dimethyl-2,3-dihydro-1*H*-quinazolino\[3,2-*f*\]phenanthridine-4,14-dione (**3l**) {#sec4.3.12}

Yellow solid. 105 mg, 47% yield; mp: 165--167 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 8.94 (d, *J* = 8.7 Hz, 1H), 8.81 (s, 1H), 8.26 (d, *J* = 7.8 Hz, 1H), 7.84 (d, *J* = 6.9 Hz, 2H), 7.44 (m, 5H), 7.26 (s, 1H), 5.25 (s, 2H), 3.41 (s, 2H), 2.64 (s, 2H), 1.09 (s, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 198.4, 162.5, 149.28, 146.9, 146.6, 136.3, 136.2, 135.3, 135.0, 131.4, 129.1, 128.7, 128.2, 127.8, 127.1, 126.6, 125.8, 119.8, 119.5, 118.1, 117.3, 109.50, 70.3, 52.7, 44.5, 33.2, 27.9; IR (KBr) ν: 2954, 1697, 1674, 1600, 1564, 1496, 1471, 1377, 1323, 1271, 1176, 827, 773, 729, 692 cm^--1^; HRMS (ESI) calcd for C~29~H~24~N~2~O~3~ \[M + H\]^+^, 449.1860; found, 449.1857.

### 6-Methyl-6,7-dihydro-4*H*-thieno\[2′,3′:3,4\]quinolino\[2,1-*b*\]quinazoline-4,9(5*H*)-dione (**3m**) {#sec4.3.13}

Yellow solid. 113 mg, 68% yield; mp: 180--182 °C; ^1^H NMR (300 MHz, CDCl~3~): δ 8.44 (d, *J* = 4.8 Hz, 1H), 8.28 (d, *J* = 7.8 Hz, 1H), 7.92--7.61 (m, 3H), 7.46 (d, *J* = 3.3 Hz, 1H), 3.55 (dt, *J* = 29.1, 13.3 Hz, 2H), 2.78 (d, *J* = 16.5 Hz, 1H), 2.62--2.37 (m, 1H), 2.25 (s, 1H), 1.21 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 196.6, 162.3, 150.8, 144.7, 135.4, 133.8, 127.3, 126.8, 126.0, 125.7, 119.4, 117.8, 46.6, 39.1, 30.1, 21.1; IR (KBr) ν: 2958, 1703, 1674, 1589, 1539, 1471, 1394, 1317, 1112, 858, 767, 692 cm^--1^; HRMS (ESI) calcd for C~19~H~14~N~2~O~2~S \[M + H\]^+^, 335.0849; found, 335.0844.

### 2,2-Dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5a**) {#sec4.3.14}

Yellow solid. 160 mg, 93% yield; mp: 190--192 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.44 (d, *J* = 7.7 Hz, 1H), 8.31 (d, *J* = 7.7 Hz, 1H), 8.25--8.21 (m, 1H), 7.96--7.91 (m, 1H), 7.91--7.86 (m, 1H), 7.80--7.76 (m, 1H), 7.32--7.26 (m, 2H), 2.89 (s, 2H), 2.50 (s, 2H), 1.13 (s, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.1, 167.0, 158.2, 152.6, 135.6, 135.1, 134.4, 129.0, 126.9, 122.7, 119.8, 118.1, 52.6, 41.2, 34.2, 28.6; IR (KBr) ν: 2975, 1691, 1669, 1599, 1379, 1298, 1248, 755, 724, 683 cm^--1^; HRMS (ESI) calcd for C~22~H~18~N~2~O~3~ \[M + H\]^+^, 359.1390; found, 359.1397.

### 2,2,6-Trimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5b**) {#sec4.3.15}

Yellow solid. 158 mg, 85% yield; mp: 207--209 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.45--8.41 (m, 1H), 8.30 (dd, *J* = 7.7, 0.9 Hz, 1H), 8.03 (d, *J* = 1.4 Hz, 1H), 7.95--7.85 (m, 2H), 7.66 (d, *J* = 8.4 Hz, 1H), 7.10 (dd, *J* = 8.4, 1.4 Hz, 1H), 2.88 (s, 2H), 2.49 (s, 2H), 2.37 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.2, 158.2, 157.1, 152.5, 135.1, 129.1, 129.0, 128.9, 128.3, 127.6, 122.4, 119.6, 118.1, 52.6, 41.2, 34.2, 28.5, 21.7; IR (KBr) ν: 2958, 2373, 1685, 1671, 1374, 1304, 1251, 814, 733, 689 cm^--1^; HRMS (ESI) calcd for C~23~H~20~N~2~O~3~ \[M + H\]^+^, 373.1547; found, 373.1543.

### 6-(*tert*-Butyl)-2,2-dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5c**) {#sec4.3.16}

Yellow solid. 155 mg, 75% yield; mp: 185--187 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.44 (d, *J* = 7.7 Hz, 1H), 8.32--8.26 (m, 2H), 7.97--7.87 (m, 2H), 7.71 (d, *J* = 8.7 Hz, 1H), 7.32 (dd, *J* = 8.7, 2.2 Hz, 1H), 2.88 (s, 2H), 2.51 (s, 2H), 1.34 (s, 9H), 1.13 (s, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.4, 158.2, 157.1, 152.4, 150.0, 135.1, 134.3, 133.1, 130.3, 129.1, 129.0, 128.3, 125.5, 124.3, 122.1, 119.2, 118.3, 52.7, 41.3, 35.2, 34.3, 31.6, 28.6; IR (KBr) ν: 2958, 2373, 1671, 1375, 1306, 1261, 1069, 687 cm^--1^; HRMS (ESI) calcd for C~26~H~26~N~2~O~3~ \[M + H\]^+^, 415.2016; found, 415.2022.

### 6-Chloro-2,2-dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5d**) {#sec4.3.17}

Yellow solid. 157 mg, 83% yield; mp: 232--234 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.42 (d, *J* = 7.7 Hz, 1H), 8.30 (d, *J* = 7.6 Hz, 1H), 8.28 (d, *J* = 2.3 Hz, 1H), 7.97--7.87 (m, 2H), 7.70 (d, *J* = 8.8 Hz, 1H), 7.25--7.22 (m, 1H), 2.87 (s, 2H), 2.49 (s, 2H), 1.12 (s, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.7, 158.1, 157.2, 153.7, 135.3, 129.1, 129.0, 128.5, 128.2, 127.1, 124.3, 121.1, 116.9, 52.4, 41.2, 34.1, 28.5; IR (KBr) ν: 2970, 2373, 1671, 1596, 1485, 1374, 1343, 1301, 1067, 686 cm^--1^; HRMS (ESI) calcd for C~22~H~17~ClN~2~O~3~ \[M + H\]^+^, 393.1000; found: 393.0991.

### 2,2,7-Trimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5e**) {#sec4.3.18}

Yellow solid. 164 mg, 88% yield; mp: 160--162 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.45--8.39 (m, 1H), 8.32--8.25 (m, 1H), 8.13--8.07 (m, 1H), 7.95--7.83 (m, 2H), 7.60 (d, *J* = 1.1 Hz, 1H), 7.07 (dd, *J* = 8.1, 1.9 Hz, 1H), 2.86 (s, 2H), 2.48 (s, 2H), 2.33 (s, 3H), 1.11 (d, *J* = 1.8 Hz, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.3, 158.1, 157.3, 151.7, 138.8, 135.6, 135.0, 134.3, 127.1, 120.1, 119.9, 118.3, 52.6, 41.2, 34.3, 28.6, 21.9; IR (KBr) ν: 2953, 2379, 1674, 1607, 1376, 1301, 1251, 1170, 831, 689 cm^--1^; HRMS (ESI) calcd for C~23~H~20~N~2~O~3~ \[M + H\]^+^, 373.1547; found, 373.1544.

### 7-Bromo-2,2-dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5f**) {#sec4.3.19}

Yellow solid. 175 mg, 80% yield; mp: 237--239 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.41 (dd, *J* = 7.7, 1.1 Hz, 1H), 8.28 (dd, *J* = 7.7, 1.2 Hz, 1H), 8.11 (d, *J* = 8.6 Hz, 1H), 7.96--7.91 (m, 2H), 7.91--7.87 (m, 1H), 7.36 (dd, *J* = 8.6, 2.0 Hz, 1H), 2.85 (s, 2H), 2.48 (s, 2H), 1.12 (s, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.9, 185.0, 158.0, 157.3, 153.0, 136.4, 135.3, 134.7, 128.5, 121.6, 117.5, 52.5, 41.3, 34.3, 28.6; IR (KBr) ν: 2964, 2368, 1680, 1658, 1368, 1296, 1243, 1173, 1070, 686 cm^--1^; HRMS (ESI) calcd for C~22~H~17~BrN~2~O~3~ \[M + H\]^+^, 437.0495; found, 437.0487.

### 2,2,8-Trimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5g**) {#sec4.3.20}

Yellow solid. 151 mg, 81% yield; mp: 266--268 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.38 (dd, *J* = 7.7, 1.1 Hz, 1H), 8.30 (dd, *J* = 7.7, 1.1 Hz, 1H), 8.08 (d, *J* = 7.8 Hz, 1H), 7.95--7.91 (m, 1H), 7.90--7.85 (m, 1H), 7.31--7.27 (m, 1H), 7.18 (d, *J* = 7.6 Hz, 1H), 3.50 (d, *J* = 18.2 Hz, 1H), 2.52 (d, *J* = 15.5 Hz, 1H), 2.40 (d, *J* = 15.5 Hz, 1H), 2.24 (d, *J* = 18.2 Hz, 1H), 2.01 (s, 3H), 1.16 (s, 3H), 1.07 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.1, 159.3, 157.1, 153.8, 135.5, 128.8, 128.7, 128.0, 125.5, 124.3, 122.4, 116.2, 52.4, 39.9, 33.4, 29.4, 27.9, 20.0; IR (KBr) ν: 2970, 1373, 1680, 1660, 1368, 1296, 1098, 786, 725, 686 cm^--1^; HRMS (ESI) calcd for C~23~H~20~N~2~O~3~ \[M + H\]^+^, 373.1547; found, 373.1550.

### 8-Fluoro-2,2-dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5h**) {#sec4.3.21}

Yellow solid. 154 mg, 82% yield; mp: 218--220 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.44--8.37 (m, 1H), 8.33--8.27 (m, 1H), 8.04 (d, *J* = 8.0 Hz, 1H), 7.97--7.85 (m, 2H), 7.35--7.27 (m, 1H), 7.12--7.03 (m, 1H), 3.52 (d, *J* = 18.3 Hz, 1H), 2.54 (d, *J* = 15.6 Hz, 1H), 2.41 (d, *J* = 15.6 Hz, 1H), 2.27 (d, *J* = 18.2 Hz, 1H), 1.17 (s, 3H), 1.07 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.7, 157.9 (d, *J* = 270 Hz), 154.4 (d, *J* = 26.3 Hz), 152.2, 135.5, 134.4, 129.6 (d, *J* = 28.8 Hz), 128.9 (d, *J* = 7.5 Hz), 126.7, 122.4, 121.3 (d, *J* = 11.3 Hz), 116.4 (d, *J* = 18.8 Hz), 115.9, 52.3, 40.5, 33.7, 29.8, 27.5; ^19^F NMR (470 MHz, CDCl~3~): δ −111.7; IR (KBr) ν: 2970, 2368, 1691, 1658, 1474, 1379, 1298, 795, 686 cm^--1^; HRMS (ESI) calcd for C~22~H~17~FN~2~O \[M + H\]^+^, 377.1296; found, 377.1300.

### 2,2-Dimethyl-2,3-dihydrobenzo\[*c*\]benzo\[6,7\]phthalazino\[2,3-*a*\]cinnoline-4,10,17(1*H*)-trione (**5i**) {#sec4.3.22}

Yellow solid. 167 mg, 82% yield; mp: 219--221 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.98 (s, 1H), 8.87 (s, 1H), 8.23 (dd, *J* = 7.7, 1.6 Hz, 1H), 8.20--8.12 (m, 2H), 7.82--7.73 (m, 3H), 7.33--7.27 (m, 2H), 2.87 (s, 2H), 2.51 (s, 2H), 1.14 (s, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.1, 158.8, 158.0, 153.1, 135.8, 135.7, 135.2, 130.7, 130.1, 128.4, 127.3, 126.9, 125.5, 124.9, 123.1, 120.2, 118.1, 52.6, 41.2, 34.2, 28.4; IR (KBr) ν: 2958, 2379, 1666, 1624, 1374, 1282, 1246, 1079, 772, 750 cm^--1^; HRMS (ESI) calcd for C~26~H~20~N~2~O~3~ \[M + H\]^+^, 409.1547; found, 409.1544.

### 2-Methyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5j**) {#sec4.3.23}

Yellow solid. 142 mg, 82% yield; mp: 201--203 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.43 (dd, *J* = 7.3, 2.3 Hz, 1H), 8.35--8.24 (m, 2H), 7.99--7.84 (m, 2H), 7.80--7.71 (m, 1H), 7.32--7.27 (m, 1H), 7.26--7.23 (m, 1H), 2.95 (d, *J* = 15.0 Hz, 1H), 2.80 (d, *J* = 21.9 Hz, 1H), 2.73--2.61 (m, 1H), 2.35 (dd, *J* = 16.9, 6.7 Hz, 2H), 1.12 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.2, 158.2, 157.2, 154.2, 135.5, 135.2, 134.4, 129.0, 127.0, 122.9, 119.9, 47.2, 35.6, 30.4, 21.6; IR (KBr) ν: 2958, 2925, 2368, 2340, 1685, 1674, 1320, 1297, 756, 687 cm^--1^; HRMS (ESI) calcd for C~21~H~16~N~2~O~3~ \[M + H\]^+^, 345.1234; found, 345.1238.

### 2,6-Dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5k**) {#sec4.3.24}

Yellow solid. 170 mg, 95% yield; mp: 230--232 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.41 (d, *J* = 7.8 Hz, 1H), 8.29 (d, *J* = 7.7 Hz, 1H), 8.07 (s, 1H), 7.93--7.84 (m, 2H), 7.64 (d, *J* = 8.4 Hz, 1H), 7.08 (d, *J* = 8.9 Hz, 1H), 2.93 (d, *J* = 18.3 Hz, 1H), 2.85--2.72 (m, 1H), 2.69--2.62 (m, 1H), 2.35 (d, *J* = 10.2 Hz, 5H), 1.12 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.3, 158.3, 157.0, 153.9, 134.3, 129.2, 129.1, 128.9, 128.4, 127.6, 122.6, 119.7, 118.5, 47.2, 35.6, 30.5, 21.8, 21.6; IR (KBr) ν: 2958, 2368, 1688, 1663, 1381, 1325, 1297, 1258, 818, 687 cm^--1^; HRMS (ESI) calcd for C~22~H~18~N~2~O~3~ \[M + H\]^+^, 359.1390; found, 359.1386.

### 6-Chloro-2-methyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5l**) {#sec4.3.25}

Yellow solid. 153 mg, 81% yield; mp: 258--260 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.40 (d, *J* = 7.6 Hz, 1H), 8.33--8.29 (m, 2H), 7.95--7.87 (m, 2H), 7.68 (d, *J* = 8.8 Hz, 1H), 7.23 (dd, *J* = 8.8, 2.3 Hz, 1H), 2.93 (d, *J* = 16.8 Hz, 1H), 2.79--2.76 (m, 1H), 2.70--2.64 (m, 1H), 2.37--2.30 (m, 2H), 1.12 (d, *J* = 5.7 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.7, 158.2, 157.2, 155.2, 134.5, 129.1, 129.0, 128.5, 128.3, 127.2, 124.5, 121.3, 117.3, 47.0, 35.7, 30.3, 21.5; IR (KBr) ν: 2953, 2362, 2340, 1688, 1669, 1318, 1293, 1240, 814 cm^--1^; HRMS (ESI) calcd for C~21~H~15~ClN~2~O~3~ \[M + H\]^+^, 379.0844; found, 379.0847.

### 6-Bromo-2-methyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5m**) {#sec4.3.26}

Yellow solid. 180 mg, 85% yield; mp: 246--248 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.47--8.29 (m, 3H), 7.95--7.87 (m, 2H), 7.65 (dd, *J* = 32.1, 8.8 Hz, 1H), 7.39--7.22 (m, 1H), 2.94 (d, *J* = 20.2 Hz, 1H), 2.86--2.73 (m, 1H), 2.73--2.61 (m, 1H), 2.42--2.29 (m, 2H), 1.11 (d, *J* = 5.8 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.7, 158.1, 157.2, 155.2, 135.3, 134.6, 129.0, 127.2, 121.5, 121.3, 46.9, 35.7, 30.3, 21.5; IR (KBr) ν: 3120, 2953, 2925, 2875, 2362, 2340, 1691, 1669, 1599, 1482, 1321, 1296, 1265, 689 cm^--1^; HRMS (ESI) calcd for C~21~H~15~BrN~2~O~3~ \[M + H\]^+^, 423.0339; found, 423.0334.

### 2,7-Dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5n**) {#sec4.3.27}

Yellow solid. 170 mg, 95% yield; mp: 287--289 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.42 (d, *J* = 7.3 Hz, 1H), 8.30 (d, *J* = 7.7 Hz, 1H), 8.16 (d, *J* = 8.2 Hz, 1H), 7.94--7.86 (m, 2H), 7.59 (s, 1H), 7.07 (dd, *J* = 8.2, 0.6 Hz, 1H), 2.91 (d, *J* = 18.1 Hz, 1H), 2.79 (d, *J* = 18.3 Hz, 1H), 2.69--2.62 (m, 1H), 2.38--2.31 (m, 5H), 1.11 (d, *J* = 5.2 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.3, 158.2, 157.3, 153.2, 138.8, 134.4, 127.2, 120.2, 120.1, 118.7, 47.2, 35.6, 30.5, 21.8, 21.6; IR (KBr) ν: 2958, 2380, 2346, 1683, 1675, 1318, 1296, 1239, 821, 688 cm^--1^; HRMS (ESI) calcd for C~22~H~18~N~2~O~3~ \[M + H\]^+^, 359.1390; found, 359.1395.

### 7-Bromo-2-methyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5o**) {#sec4.3.28}

Yellow solid. 171 mg, 81% yield; mp: 267--269 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.43--8.41 (m, 1H), 8.31 (dd, *J* = 7.6, 1.2 Hz, 1H), 8.18 (d, *J* = 8.7 Hz, 1H), 7.96--7.88 (m, 3H), 7.38 (dd, *J* = 8.7, 2.0 Hz, 1H), 2.91 (d, *J* = 18.5 Hz, 1H), 2.78 (d, *J* = 28.9 Hz, 1H), 2.67 (d, *J* = 12.2 Hz, 1H), 2.36--2.32 (m, 2H), 1.12 (d, *J* = 6.1 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.9, 158.0, 157.3, 154.5, 136.4, 135.4, 134.7, 128.5, 121.8, 117.9, 47.1, 35.7, 30.4, 21.6; IR (KBr) ν: 2964, 2368, 1677, 1315, 1296, 1229, 783, 686 cm^--1^; HRMS (ESI) calcd for C~21~H~15~BrN~2~O~3~ \[M + H\]^+^, 423.0339; found, 423.0334.

### 2,8-Dimethyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5p**) {#sec4.3.29}

Yellow solid. 152 mg, 85% yield; mp: 217--219 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.39--8.36 (m, 1H), 8.30 (dd, *J* = 7.7, 0.8 Hz, 1H), 8.08 (dd, *J* = 18.7, 7.9 Hz, 1H), 7.93--7.91 (m, 1H), 7.88--7.85 (m, 1H), 7.30--7.27 (m, 1H), 7.17 (d, *J* = 7.4 Hz, 1H), 3.04 (dd, *J* = 17.9, 11.0 Hz, 1H), 2.69--2.60 (m, 2H), 2.40--2.34 (m, 2H), 2.01 (d, *J* = 7.5 Hz, 3H), 1.11 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.4, 159.8, 159.3, 157.3, 157.2, 155.5, 155.0, 134.1, 131.9, 130.9, 128.9, 128.7, 128.0, 124.4, 117.0, 116.7, 47.2, 35.7, 27.8, 21.9, 20.1; IR (KBr) ν: 2958, 2875, 1685, 1672, 1602, 1376, 1321, 1293, 1243, 781, 683 cm^--1^; HRMS (ESI) calcd for C~22~H~18~N~2~O~3~ \[M + H\]^+^, 359.1390; found, 359.1397.

### 2-Phenyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5q**) {#sec4.3.30}

Yellow solid. 175 mg, 86% yield; mp: 188--190 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.48--8.42 (m, 1H), 8.32 (dd, *J* = 7.6, 1.8 Hz, 1H), 8.26 (d, *J* = 8.1 Hz, 1H), 8.06--7.58 (m, 4H), 7.47--7.31 (m, 3H), 7.30--7.27 (m, 3H), 3.53--3.46 (m, 1H), 3.34--3.29 (m, 1H), 3.12 (d, *J* = 17.3 Hz, 1H), 2.96--2.86 (m, 2H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.5, 158.2, 157.3, 153.8, 142.4, 135.3, 134.4, 129.3, 128.6, 128.5, 127.8, 127.5, 127.1, 126.1, 125.2, 122.8, 119.9, 45.8, 40.8, 35.3; IR (KBr) ν: 3064, 2964, 2373, 2340, 1672, 1652, 1290, 1248, 733, 692 cm^--1^; HRMS (ESI) calcd for C~26~H~18~N~2~O~3~ \[M + H\]^+^, 407.1390; found, 407.1390.

### 6-Chloro-2-phenyl-2,3-dihydrobenzo\[*c*\]phthalazino\[2,3-*a*\]cinnoline-4,10,15(1*H*)-trione (**5r**) {#sec4.3.31}

Yellow solid. 179 mg, 81% yield; mp: 186--188 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.40 (dd, *J* = 11.6, 5.0 Hz, 2H), 8.25 (d, *J* = 7.7 Hz, 1H), 7.95--7.91 (m, 2H), 7.71 (d, *J* = 8.9 Hz, 1H), 7.36--7.33 (m, 3H), 7.28--7.27 (m, 2H), 7.25 (s, 1H), 3.50--3.45 (m, 1H), 3.33--3.28 (m, 1H), 3.12 (d, *J* = 19.2 Hz, 1H), 2.90 (d, *J* = 9.5 Hz, 2H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.0, 158.2, 157.2, 154.8, 142.2, 135.4, 134.6, 133.8, 132.7, 130.1, 129.3, 129.1, 128.6, 128.5, 127.9, 127.3, 127.1, 124.4, 121.3, 117.5, 45.7, 40.7, 35.4; IR (KBr) ν: 3070, 2379, 1694, 1672, 1596, 1374, 1298, 1251, 1184, 1070, 697 cm^--1^; HRMS (ESI) calcd for C~26~H~17~ClN~2~O~3~ \[M + H\]^+^, 441.1000; found, 441.1005.

### 1*H*-Cyclopenta\[*c*\]phthalazino\[2,3-*a*\]cinnoline-3,9,14(2*H*)-trione (**5s**) {#sec4.3.32}

Yellow solid. 136 mg, 86% yield; mp: 252--254 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.46 (m, 1H), 8.35 (dd, *J* = 7.8, 1.1 Hz, 1H), 8.23 (dd, *J* = 7.2, 2.0 Hz, 1H), 7.97--7.94 (m, 1H), 7.92--7.89 (m, 1H), 7.79--7.77 (m, 1H), 7.32--7.27 (m, 2H), 3.46--3.36 (m, 2H), 2.73--2.61 (m, 2H); ^13^C NMR (125 MHz, CDCl~3~): δ 196.1, 167.9, 165.9, 157.3, 156.4, 156.2, 153.9, 153.6, 128.5, 125.7, 123.0, 122.8, 122.7, 122.3, 122.2, 119.9, 119.8, 118.9, 118.5, 115.6, 115.4, 114.9, 114.7, 47.2, 35.6, 30.4, 21.6; IR (KBr) ν: 3075, 2925, 2379, 2340, 1702, 1674, 1630, 1602, 1382, 1326, 1304, 1251, 1062, 692 cm^--1^; HRMS (ESI) calcd for C~19~H~12~N~2~O~3~ \[M + H\]^+^, 317.0921; found, 317.0920.

### Ethyl 6-Methyl-8,13-dioxo-8,13-dihydrophthalazino\[2,3-*a*\]cinnoline-5-carboxylate (**5t**) {#sec4.3.33}

Yellow solid. 146 mg, 84% yield; mp: 112--114 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.44--8.37 (m, 1H), 8.34--8.26 (m, 1H), 7.93--7.78 (m, 3H), 7.32--7.27 (mz, 1H), 7.27--7.24 (m, 1H), 7.22--7.17 (m, 1H), 4.44--4.36 (m, 2H), 2.40 (d, *J* = 1.5 Hz, 3H), 1.41--1.36 (m, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 166.4, 157.6, 141.2, 134.4, 128.5, 123.9, 119.9, 119.4, 62.0, 17.9, 14.6; IR (KBr) ν: 2968, 2368, 1722, 1677, 1307, 1229, 1162, 775, 692 cm^--1^; HRMS (ESI) calcd for C~20~H~16~N~2~O~4~ \[M + H\]^+^, 349.1183; found, 349.1174.

### Ethyl 3,6-Dimethyl-8,13-dioxo-8,13-dihydrophthalazino\[2,3-*a*\]cinnoline-5-carboxylate (**5u**) {#sec4.3.34}

Yellow solid. 154 mg, 85% yield; mp: 154--155 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.39 (dd, *J* = 7.5, 0.8 Hz, 1H), 8.29 (dd, *J* = 8.3, 3.0 Hz, 1H), 7.92--7.80 (m, 2H), 7.72 (dd, *J* = 8.3, 2.7 Hz, 1H), 7.07 (s, 2H), 4.41 (q, *J* = 7.1 Hz, 2H), 2.38 (s, 3H), 2.33 (s, 3H), 1.39 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 166.5, 157.6, 157.5, 140.5, 136.7, 134.7, 134.2, 133.2, 130.1, 129.5, 129.2, 128.7, 128.2, 125.3, 123.6, 119.7, 119.5, 61.9, 21.6, 17.9, 14.6; IR (KBr) ν: 2981, 2932, 1733, 1659, 1607, 1319, 1232, 1177, 1047, 690 cm^--1^; HRMS (ESI) calcd for C~21~H~18~N~2~O~4~ \[M + H\]^+^, 363.1339; found, 363.1334.

### Ethyl 3-Chloro-6-methyl-8,13-dioxo-8,13-dihydrophthalazino\[2,3-*a*\]cinnoline-5-carboxylate (**5v**) {#sec4.3.35}

Yellow solid. 170 mg, 89% yield; mp: 163--164 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.39 (d, *J* = 7.0 Hz, 1H), 8.30 (dd, *J* = 7.5, 0.8 Hz, 1H), 7.94--7.84 (m, 2H), 7.76 (d, *J* = 8.9 Hz, 1H), 7.32 (d, *J* = 2.3 Hz, 1H), 7.22 (dd, *J* = 8.8, 2.3 Hz, 1H), 4.41 (q, *J* = 7.1 Hz, 2H), 2.42 (s, 3H), 1.40 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 165.8, 157.7, 157.6, 142.9, 134.9, 134.6, 134.0, 132.3, 129.9, 129.5, 128.9, 128.4, 128.3, 125.5, 125.0, 121.3, 118.1, 62.2, 18.0, 14.6; IR (KBr) ν: 2992, 2365, 2338, 1717, 1671, 1385, 1328, 1224, 1058, 688 cm^--1^; HRMS (ESI) calcd for C~20~H~15~ClN~2~O~4~ \[M + H\]^+^, 383.0793; found, 383.0795.

### Ethyl 2,6-Dimethyl-8,13-dioxo-8,13-dihydrophthalazino\[2,3-*a*\]cinnoline-5-carboxylate (**5w**) {#sec4.3.36}

Yellow solid. 156 mg, 86% yield; mp: 122--123 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.43--8.37 (m, 1H), 8.32--8.27 (m, 1H), 7.87 (dtd, *J* = 18.8, 7.4, 1.4 Hz, 2H), 7.66 (s, 1H), 7.19 (d, *J* = 8.0 Hz, 1H), 7.01 (dd, *J* = 8.0, 0.6 Hz, 1H), 4.39 (q, *J* = 7.1 Hz, 2H), 2.39 (s, 3H), 2.33 (s, 3H), 1.38 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 166.5, 157.7, 157.6, 140.2, 138.9, 135.7, 134.6, 134.4, 130.1, 129.6, 128.7, 128.2, 127.7, 124.9, 121.2, 120.1, 119.6, 61.9, 21.9, 17.8, 14.6; IR (KBr) ν: 2984, 2934, 2355, 2344, 1719, 1667, 1313, 1234, 1058, 688 cm^--1^; HRMS (ESI) calcd for C~21~H~18~N~2~O~4~ \[M + H\]^+^: 363.1339; found, 363.1337.

### Ethyl 2-Bromo-6-methyl-8,13-dioxo-8,13-dihydrophthalazino\[2,3-*a*\]cinnoline-5-carboxylate (**5x**) {#sec4.3.37}

Yellow solid. 196 mg, 92% yield; mp: 182--183 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.39 (d, *J* = 7.4 Hz, 1H), 8.32--8.26 (m, 1H), 8.00 (d, *J* = 1.7 Hz, 1H), 7.93--7.83 (m, 2H), 7.32 (dd, *J* = 8.5, 1.7 Hz, 1H), 7.18 (d, *J* = 8.4 Hz, 1H), 4.39 (q, *J* = 7.1 Hz, 2H), 2.39 (s, 3H), 1.38 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 165.9, 157.7, 157.5, 142.2, 136.6, 134.9, 134.7, 129.9, 129.8, 129.5, 128.9, 128.4, 126.4, 122.9, 122.8, 121.9, 118.7, 62.1, 18.0, 17.9, 14.6; IR (KBr) ν: 2987, 2360, 2338, 1719, 1671, 1317, 1238, 1053, 804, 690 cm^--1^; HRMS (ESI) calcd for C~20~H~15~BrN~2~O~4~ \[M + H\]^+^, 427.0288; found, 427.0293.
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